Dr. Dolly Jacob has over 20 years’ experience in the pharmaceutical industry, spanning from preclinical formulation development, through early clinical formulation development into late-stage product development. In her role as Director, Integrated Development Services, Early Development she is responsible for providing scientific and technical support to business development team for early drug product development strategies and implementation. Since joining Quotient Sciences in 2015, Dolly has led and supported development teams and global Translational Pharmaceutics programs.

Dolly has an interest in enabling technologies for bioavailability enhancement and innovative strategies to develop formulations for challenging molecules and clinical indications.

Previously Dolly has worked for 3M Healthcare, Astra Zeneca and Cipla Ltd. Dolly’s experience and expertise spans a wide range of dosage forms and drug delivery systems, including oral products, modified release, sterile parenteral, topical and solubility enhancing technologies.

Dolly holds a PhD in Pharmaceutical Sciences from De Montfort University, UK and Bachelor and Master Pharmacy degrees from Universities in India.